Department of Clinical Sciences


Investigators' Day
Friday, Sept. 30, 2016


Friday, September 30, 2016
9:15am - 5:00pm
Veterinary Research Tower,
Lecture Hall III

Judge's Evaluation Form
Research Proposal Evaluation Form

? Please feel free to contact the co-chairs of the program:

Elizabeth Buckles
Mary Martin
Tracy Stokol

2016 Judges

AltierCraig Altier, Professor and Chair, Department of Population Medicine and Diagnostic Sciences, Cornell University
Dr. Altier earned his DVM in 1985 from The Ohio State University and PhD in 1996 from Case Western Reserve University. Dr. Altier joined the Cornell faculty in 2006 as Associate Professor in the Bacteriology Laboratory of the Animal Health Diagnostic Center.
He has served on numerous University committees and national panels and is an internationally recognized expert on food safety and bacterial pathogenesis. Dr. Altier’s current research is funded by the USDA and the NIH and seeks to understand the means by which the bacterial pathogen Salmonella responds to its environment to express traits necessary for survival and virulence.

Jim CaseyJames W. Casey, PhD, Associate Professor of Virology,
Department of Microbiology and Immunology, Cornell University

Dr. Casey received the BS degree in Biology from Wayne State University in 1966 and his PhD from the University of Chicago in 1973 studying Biology. Dr. Casey was a postdoctoral fellow at Cal Tech from 1974-1980 where he studied molecular virology in the laboratory of Norman Davidson.
Dr. Casey’s research focuses in two lines of investigation. Oncogenesis in wild populations, primarily in fish and marine turtles, an understudied field that has provided new insights into viral agents responsible for this disease. More recently, Dr. Casey has turned his attention to the recent outbreak of viral hemorrhagic septicemia (VHSV) in the Great Lakes, an agent having a major impact on numerous species inhabiting these waters.

Scott PalmerScott Palmer, VMD, Adjunct Professor, Department of Population Medicine & Diagnostic Sciences, Cornell University; New York State Equine Medical Director

Dr. Palmer is a renowned veterinarian who, as the New York State Equine Medical Director, oversees the health and safety of horses at all New York State Thoroughbred and Standardbred racetracks. Since graduating from the University of Pennsylvania, School of Veterinary Medicine in 1976, Dr. Palmer has worked as a staff clinician at the New Jersey Equine Clinic, serving as the Hospital Director from 1997 through 2013.
He is a two-time recipient of the New Jersey Equine Practitioners Veterinarian of the Year award, as well as a recipient of the AAEP President’s Award in 2009 and the AAEP Distinguished Service Award in 2010. Dr. Palmer is board certified in equine practice by the American Board of Veterinary Practitioners and has authored dozens of peer-reviewed publications and is a featured speaker at veterinary conferences world-wide.

Heidi Reesink
Heidi Reesink, VMD, PhD, Assistant Professor of Large Animal Surgery, Department of Clinical Sciences, Cornell University
Dr. Reesink was recently appointed Assistant Professor in the section of Large Animal Medicine.  She completed a large animal residency at Cornell in 2012 and earned her VMD from University of Pennsylvania in 2007.  Dr. Reesink’s clinical interests include large animal orthopedic surgery, equine sports medicine, lameness and emergency surgery. She is interested in translating novel research discoveries, including regenerative medicine, stem cell therapy, and lubricin therapy, to equine clinical patients with musculoskeletal disease.
Dr. Reesink’s laboratory aims to unravel basic mechanisms underlying the development of orthopedic disease and to pioneer innovative therapies for the treatment of joint injury and arthritis in equine and human athletes. The lab is broadly interested in the use of regenerative medicine, including the use of stem cell therapy and secreted molecules, for the treatment of musculoskeletal disease. An area of active investigation is understanding how the glycoprotein lubricin protects against joint disease and how lubricin therapy may be employed to prevent additional cartilage damage and ameliorate arthritis.